IP Library Granted Patent US 10,827,753
Granted Patent B2
US 10,827,753 · App. 16/507,535 · Granted Nov 10, 2020

Compositions and methods for controlling nematodes

Inventors: Deryck J. Williams (University City, MO); Matt W. Dimmic (Maryland Heights, MO); William P. Haakenson (St. Louis, MO); Al Wideman (St. Louis, MO); Barry J. Shortt (New Melle, MO); Tim Cheeseright (Hertfordshire, GB); Michael J. Crawford (St. Louis, MO)
Assignee: Monsanto Technology LLC
A01N43/22A01N43/56A01N43/76A01N43/78A01N43/82A01N47/12A01N57/28A01N57/30A01N57/32C07D405/04C07D413/04C07D413/14C07D417/04
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,827,753
App. No.
16/507,535
Granted
Nov 10, 2020
Kind
B2
Abstract

Compositions and methods for controlling nematodes are described herein, e.g., nematodes that infest plants or animals. The compounds include oxazoles, oxadiazoles and thiadiazoles.

Claims (68)

1. A nematicidal composition comprising:

an effective amount of a compound of Formula IV, Formula V, or a salt thereof

wherein,

A is phenyl, pyrazyl, oxazolyl or isoxazolyl, each of which can be optionally independently substituted with one or more substituents selected from the group consisting of halogen, CF 3 , CH 3 , OCF 3 , OCH 3 , CN, and C(H)O; and

C is thienyl, furanyl, oxazolyl or isoxazolyl, each of which can be optionally independently substituted with one or more substituents selected from the group consisting of fluorine, chlorine, CH 3 , and OCF 3 ; and

one or more of an insecticide, a fungicide, a herbicide, or another pesticide selected from the group consisting of an avermectin, milbemycin, imidacloprid, aldicarb, oxamyl, fenamiphos, fosthiazate, metam sodium, etridiazole, penta-chloro-nitrobenzene (PCNB), flutolanil, metalaxyl, mefonoxam, fosetyl-al, silthiofam, fludioxonil, myclobutanil, azoxystrobin, chlorothalonil, propiconazole, tebuconazole, pyraclostrobin, trifloxysulfuron, glyphosate, and halosulfuron.

2. The composition of claim 1 wherein A is phenyl.

3. The composition of claim 1 wherein A is pyrazyl.

4. The composition of claim 1 wherein A is oxazolyl.

5. The composition of claim 1 wherein A is isoxazolyl.

6. The composition of claim 1 wherein C is thienyl.

7. The composition of claim 1 wherein C is furanyl.

8. The composition of claim 1 wherein C is oxazolyl.

9. The composition of claim 1 wherein C is isoxazolyl.

10. The composition of claim 1 comprising a compound of Formula IVa or a salt thereof,

wherein R 1 and R 5 are independently selected from hydrogen, CH 3 , F, Cl, Br, CF 3 and OCF 3 ;

R 2 and R 4 are independently selected from hydrogen, F, Cl, Br, and CF 3 ;

R 3 is selected from hydrogen, CH 3 , CF 3 , F, Cl, Br, OCF 3 , OCH 3 , CN, and C(H)O;

R 7 and R 8 are independently selected from hydrogen and fluorine;

R 9 is selected from hydrogen, F, Cl, CH 3 , and OCF 3 ; and

E is O or S.

11. The composition of claim 1 comprising a compound of Formula IVb or a salt thereof,

wherein R 1 and R 5 are independently selected from hydrogen, CH 3 , F, Cl, Br, CF 3 and OCF 3 ;

R 2 and R 4 are independently selected from hydrogen, F, Cl, Br, and CF 3 ;

R 3 is selected from hydrogen, CH 3 , CF 3 , F, Cl, Br, OCF 3 , OCH 3 , CN, and C(H)O;

R 8 is selected from hydrogen and fluorine;

R 6 and R 9 are independently selected from hydrogen, F, Cl, CH 3 , and OCF 3 ; and

E is O or S.

12. The composition of claim 1 comprising a compound of Formula Va or a salt thereof,

wherein, R 1 and R 5 are independently selected from hydrogen, CH 3 , F, Cl, Br, CF 3 and OCF 3 ;

R 2 and R 4 are independently selected from hydrogen, F, Cl, Br, and CF 3 ;

R 3 is selected from hydrogen, CH 3 , CF 3 , F, Cl, Br, OCF 3 , OCH 3 , CN, and C(H)O;

R 7 and R 8 are independently selected from hydrogen and fluorine;

R 9 is selected from hydrogen, F, Cl, CH 3 , and OCF 3 ;

and E is O or S.

13. The composition of claim 1 comprising a compound of Formula Vb or a salt thereof,

wherein R 1 and R 5 are independently selected from hydrogen, CH 3 , F, Cl, Br, CF 3 and OCF 3 ;

R 2 and R 4 are independently selected from hydrogen, F, Cl, Br, and CF 3 ;

R 3 is selected from hydrogen, CH 3 , CF 3 , F, Cl, Br, OCF 3 , OCH 3 , CN, and C(H)O;

R 8 is selected from hydrogen and fluorine;

R 6 and R 9 are independently selected from hydrogen, F, Cl, CH 3 , and OCF 3 ; and

E is O or S.

14. The composition of claim 10 wherein E is O.

15. The composition of claim 10 wherein E is S.

16. The composition of claim 1 comprising a compound selected from the group consisting of:

3-phenyl-5-(thiophen-2-yl)-1,2,4-oxadiazole,

5-(furan-2-yl)-3-phenyl-1,2,4-oxadiazole,

3-(4-fluorophenyl)-5-(thiophen-2-yl)-1,2,4-oxadiazole,

3-(4-fluorophenyl)-5-(furan-2-yl)-1,2,4-oxadiazole,

3-(4-chlorophenyl)-5-(thiophen-2-yl)-1,2,4-oxadiazole,

3-(4-chlorophenyl)-5-(furan-2-yl)-1,2,4-oxadiazole,

3-(4-bromophenyl)-5-(thiophen-2-yl)-1,2,4-oxadiazole,

3-(4-bromophenyl)-5-(furan-2-yl)-1,2,4-oxadiazole,

3-(4-chloro-2-methylphenyl)-5-(furan-2-yl)-1,2,4-oxadiazole,

3-(2,4-dichlorophenyl)-5-(furan-2-yl)-1,2,4-oxadiazole,

3-(4-chlorophenyl)-5-(thiophen-3-yl)-1,2,4-oxadiazole,

3-(4-chlorophenyl)-5-(furan-3-yl)-1,2,4-oxadiazole,

3-(4-fluorophenyl)-5-(thiophen-3-yl)-1,2,4-oxadiazole, and

3-(4-fluorophenyl)-5-(furan-3-yl)-1,2,4-oxadiazole.

17. The composition of claim 16 comprising 3-phenyl-5-(thiophen-2-yl)-1,2,4-oxadiazole.

18. The composition of claim 1 further comprising water.

19. The composition of claim 1 in the form of a concentrate.

20. The composition of claim 1 further comprising a solvent in which the compound of Formula IV, Formula V, or a salt thereof is dissolved.

21. The composition of claim 20 further comprising a co-solvent.

22. The composition of claim 21 wherein the co-solvent is selected from the group consisting of ethyl lactate, methyl soyate, isopropanol, acetone, 1,2-propanediol, n-alkylpyrrolidone, petroleum-based oil and mineral oil.

23. The composition of claim 1 further comprising an aqueous surfactant.

24. The composition of claim 1 further comprising a permeation enhancer.

25. The composition of claim 16 comprising 5-(furan-2-yl)-3-phenyl-1,2,4-oxadiazole.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 10, 2019
From: WILLIAMS, DERYCK J.; DIMMIC, MATT W.; HAAKENSON, WILLIAM P., JR.; WIDEMAN, AL; SHORTT, BARRY J.; CHEESERIGHT, TIM; CRAWFORD, MICHAEL J.
To: DIVERGENCE, INC.
Reel/Frame 049714/0195 →
MERGER Recorded Jul 10, 2019
From: DIVERGENCE, INC.
To: MONSANTO COMPANY
Reel/Frame 049714/0334 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 10, 2019
From: MONSANTO COMPANY
To: MONSANTO TECHNOLOGY LLC
Reel/Frame 049714/0443 →
Continuity (7)
Continuation 16137641 · Sep 21, 2018
Division 15415170 · Jan 25, 2017
Division 14790726 · Jul 2, 2015
Continuation 13856236 · Apr 3, 2013
Division 12190989 · Aug 13, 2008
Provisional Application 60955448 · Aug 13, 2007
Related Publication 20190343120A1 · Nov 14, 2019